Sequencing of glutamatergic pathway genes in alcohol and nicotine co-dependence

酒精和尼古丁相互依赖性中谷氨酸能途径基因的测序

• 批准号: 8093992
• 负责人: LINGJUN ZUO
• 金额: $ 18.82万
• 依托单位: YALE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-04-01 至 2013-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8093992
• 关键词: Affect; Alcohol dependence; Alcohols; Bioinformatics; Biological; Biological Process; Computer Simulation; DNA; Data; Dependence; Detection; Dideoxy Chain Termination DNA Sequencing; Disease; Foundations; Frequencies; Funding; Future; Gene Expression; Gene Targeting; Genes; Genetic; Genotype; Glutamate Receptor; Glutamates; Glycine Receptors; Human; Individual; Investigation; Joints; Maps; Methods; Modeling; N-Methylaspartate; Neurosciences; Neurotrophic Tyrosine Kinase Receptor Type 2; Nicotine; Nicotine Dependence; Nucleotides; Pathway interactions; Phenotype; Play; Prevention; Prevention strategy; Public Health; Research; Risk; Role; Sample Size; Sampling; Smoking; System; Technology; Testing; Variant; addiction; alcohol response; base; cost; design; effective therapy; follow-up; genetic association; genetic variant; genome wide association study; kainate; metabotropic glutamate receptor type 1; new technology; next generation; novel; protein function; protein structure; tool; trait; treatment strategy

DESCRIPTION (provided by applicant): It has been suggested that genetic factors may contribute to alcohol and nicotine co-dependence (AD+ND). Glutamatergic pathway plays important functional roles in addiction. Glutamatergic pathway genes have been demonstrated to be associated with smoking related traits and human variation in alcohol response by genome-wide studies. However, the genetic functional variants underlying AD+ND are largely unidentified. This study mainly aims to identify the potential functional variants underlying AD+ND in glutamatergic pathway, in particular, the variants with low frequencies or weak effects. We select five target genes, including GRIN2B (glutamate receptor, ionotropic, N-methyl D-aspartate 2B), GRM1 (glutamate receptor, metabotropic 1), GRIK1 (glutamate receptor, ionotropic, kainate 1), GLRA2 (glycine receptor, alpha 2) and NTRK2 (neurotrophic tyrosine kinase, receptor, type 2). These regions will be sequenced in a relatively large size of sample (448 AD+ND cases and 448 controls) by a novel next generation sequence approach, i.e., targeted paired-end multiplexed (TPM) sequencing. Both individual effects and joint effects of the five genes on AD+ND will be tested in two independent samples. If successful, this study would make big progress in the research on the mechanism of AD+ND and may be helpful in developing novel and effective treatment and prevention strategies for AD+ND. Furthermore, the expected findings could provide a much detailed map of genetic variants, in particular, rare variants, in the five target regions, which would lay a foundation for future investigation on genotype-phenotype relationship. PUBLIC HEALTH RELEVANCE: This proposed project will search for causal loci for alcohol and nicotine co-dependence, which will help us better understand the biological basis of this phenotype. The expected findings would significantly contribute to the improvement of public health.

描述(由申请人提供)：有研究表明，遗传因素可能导致酒精和尼古丁的共同依赖(AD+ND)。谷氨酸能通路在成瘾中起着重要的作用。全基因组研究已经证明谷氨酸途径基因与吸烟相关的特征和人类酒精反应的变异有关。然而，AD+ND的遗传功能变异在很大程度上是未知的。本研究主要目的是找出AD+ND在谷氨酸能通路中潜在的功能变异，特别是频率较低或作用较弱的变异。我们选择了5个靶基因，包括GRIN2B(谷氨酸受体，离子亲和性，N-甲基D-天冬氨酸2B)，GRM1(谷氨酸受体，代谢性1)，GRIK1(谷氨酸受体，离子亲电性，红藻氨酸1)，GLRA2(甘氨酸受体，α2)和NTRK2(神经营养酪氨酸激酶，受体，2型)。这些区域将通过一种新的下一代测序方法在相对较大的样本(448例AD+ND病例和448例对照)中进行测序，即靶向配对末端多路(TPM)测序。这五个基因对AD+ND的单独效应和联合效应将在两个独立的样本中进行检验。如果成功，本研究将在AD+ND的发病机制研究方面取得重大进展，并可能有助于开发新的、有效的AD+ND的治疗和预防策略。此外，预期的发现可能会提供五个靶区的遗传变异，特别是稀有变异的详细图谱，这将为未来研究基因-表型关系奠定基础。 公共卫生相关性：这个拟议的项目将寻找酒精和尼古丁相互依赖的因果基因，这将帮助我们更好地理解这种表型的生物学基础。预期的结果将大大有助于改善公共卫生。